Michael Sch News Today

Massive demographic changes have been hoisted upon the American People. And theyre changes that none of us ever voted for, and most of us dont like. From virginia to california, we see stark examples of how radically in some ways the country has changed. Now, much of this is related to both illegal and in some cases Legal Immigration that, of course, progressives love. And since this is the last speech that i will give as president , i think its fitting to leave one final thought. An observation...

Contact Nicole Weber T +49 6172 686-2394 nicole.weber@fresenius.com Documents ...

Digital memory test and a blood sample - this combination will be tested for its potential to identify early Alzheimer's disease in a new research study. Over a hundred healthcare centers are part of the study that is now inviting participants to sign up. At least 3,000, preferably many more participants are needed for the study to be successful.

The head of the defence unit of European aerospace giant Airbus has expressed understanding for the decision by German Chancellor Olaf Scholz not to provide Ukraine with the German-made Taurus cruise missile. Speaking to news magazine Der Spiegel, Airbus Defence and Space chief executive Michael Schöllhorn said that technical solutions could be found to avoid direct German participation in programming the missiles in Ukraine, in remarks published on Saturday. "But I can comprehend the ...

/PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological...

Wacker Chemie shares are likely to continue their downward slide on Wednesday following a pessimistic analyst commentary. On Tradegate, the shares of the specialty chemicals company lost 1.6 percent...

LANXESS is reshuffling the management positions in four of its ten business units. In doing so, the Group aims to provide additional impetus for its business in the Consumer Protection segment and ...

EQS-News: Formycon AG / Key word(s): Regulatory AdmissionFormycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration 30.11.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press R...

It was the greatest rebuttal to the dull face of road cycling

A new voluntary electronic identity (e-ID) scheme, overseen by the Swiss authorities, could be launched in 2026 in the Alpine country.